Status:
COMPLETED
Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension
Lead Sponsor:
Rania Ali El-Farrash
Conditions:
Persistent Pulmonary Hypertension
Eligibility:
All Genders
1-10 years
Phase:
PHASE1
Brief Summary
Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.
Detailed Description
40 neonates with PPHN, met inclusion criteria, randomly assigned to 2 groups, each includes 20, first group received intravenous milrinone and second group received nasogastric sildenafil. both groups...
Eligibility Criteria
Inclusion
- gestational age \>34 weeks
- postnatal age \<10 days
Exclusion
- neonates with congenital heart disease
- neonates with congenital diaphragmatic hernia
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04391478
Start Date
January 1 2015
End Date
September 1 2015
Last Update
May 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.